Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-16T04:47:14.482Z Has data issue: false hasContentIssue false

Do Results of Surveillance Cultures Impact the Choice of Empirical Antibiotics Among Patients with Carbapenem-Resistant Acinetobacter baumannii Infections?

Published online by Cambridge University Press:  10 September 2015

Rossana Rosa
Affiliation:
Department of Medicine, Jackson Memorial Hospital, Miami, Florida
Jose Castro
Affiliation:
Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida
Rachel Latibeaudiere
Affiliation:
Department of Medicine, Jackson Memorial Hospital, Miami, Florida
Nicholas Namias
Affiliation:
Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida
L. Silvia Munoz-Price*
Affiliation:
Institute for Health and Society and Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin
*
Address correspondence to L. Silvia Munoz-Price, Institute for Health and Society and Department of Medicine, Froedtert and the Medical College of Wisconsin Health Research Center, P.O. Box 26509, Milwaukee WI 53226 (smunozprice@mcw.edu).
Rights & Permissions [Opens in a new window]

Abstract

We aimed to determine whether the results of surveillance cultures were associated with use of appropriate empirical antibiotic therapy among patients with carbapenem-resistant Acinetobacter baumannii infections. We found that surveillance status was not associated with appropriate empirical antibiotic therapy (P=.36). There were significant delays to concordant therapy among surveillance-positive patients (P=.03).

Infect. Control Hosp. Epidemiol. 2015;36(12):1455–1457

Information

Type
Concise Communications
Copyright
© 2015 by The Society for Healthcare Epidemiology of America. All rights reserved 
Figure 0

TABLE 1Baseline Demographic Characteristics and Distribution of Clinical Acinetobacter baumannii Infections Based on Surveillance Status Prior to the Onset of Infection

Figure 1

Figure 1Probability of receiving appropriate antimicrobial therapy (concordant) against carbapenem-resistant Acinetobacter baumannii based on results of surveillance cultures. Curves represent the probability of not receiving concordant therapy. Days represent the days from onset of signs and symptoms of infection until concordant therapy was started. Solid line represents the group that remained surveillance-negative. Dashed line represents the group that was surveillance-positive. Shaded area depicts the 95% confidence intervals.